Nellcor/Masimo
This article was originally published in The Gray Sheet
Executive Summary
Tyco/Nellcor will pay Masimo an ongoing royalty for the right to sell its new line of pulse oximetry products under a patent litigation settlement announced Jan. 23. All pending litigation between the market rivals is dismissed (1"The Gray Sheet" April 5, 2004, p. 26). Nellcor has paid Masimo $265 mil. for damages and $65 mil. in advanced royalties as of Jan. 31...